Inhibition of experimental arterial thrombosis in dogs with platelet-deaggregating agents.
D000284:Administration, Oral; D000818:Animals; D001241:Aspirin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects; D002339:Carotid Arteries / Q000473:pathology / Q000601:surgery; D003533:Cyproheptadine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D004176:Dipyridamole / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004285:Dogs; D005263:Femoral Artery / Q000473:pathology / Q000601:surgery; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D007275:Injections, Intravenous; D007785:Lactose / Q000008:administration & dosage / Q000494:pharmacology; D008722:Methods; D010973:Platelet Adhesiveness / Q000187:drug effects*; D013927:Thrombosis / Q000517:prevention & control*; D013997:Time Factors
D003533:Cyproheptadine; D004176:Dipyridamole; D006493:Heparin; D007785:Lactose; D001241:Aspirin